We are live on ! Find out more
AET

Aetna Inc
AET

Delisted

AET was delisted on the 28th of November, 2018.

880 hedge funds and large institutions have $39.4B invested in Aetna Inc in 2017 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 304 increasing their positions, 358 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 75

4% more funds holding in top 10

Funds holding in top 10: 2425 (+1)

0% more funds holding

Funds holding: 877880 (+3)

0% less capital invested

Capital invested by funds: $39.6B → $39.4B (-$183M)

15% less repeat investments, than reductions

Existing positions increased: 304 | Existing positions reduced: 358

36% less call options, than puts

Call options by funds: $523M | Put options by funds: $822M

Holders
880
Holders Change
+3
Holders Change %
+0.34%
% of All Funds
21.91%
Holding in Top 10
25
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.17%
% of All Funds
0.62%
New
89
Increased
304
Reduced
358
Closed
75
Calls
$523M
Puts
$822M
Net Calls
-$300M
Net Calls Change
-$405M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$3.92B +$3.75B +29,828,390 +3,375%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.95B +$105M +838,578 +4%
State Street
3
State Street
Massachusetts
$2.76B +$5.65M +45,022 +0.2%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$2.73B -$890M -7,085,290 -25%
Capital World Investors
5
Capital World Investors
California
$2.43B +$823M +6,554,735 +52%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$1.05B -$145M -1,154,835 -12%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$1.01B +$21M +167,261 +2%
AllianceBernstein
8
AllianceBernstein
Tennessee
$705M -$14.4M -114,857 -2%
JP Morgan Chase
9
JP Morgan Chase
New York
$662M -$365M -2,903,144 -36%
GCM
10
Glenview Capital Management
New York
$641M -$20.7M -164,991 -3%
JHIU
11
Janus Henderson Investors US
Colorado
$565M -$57.5M -457,869 -9%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$559M +$20.8M +165,278 +4%
DSA
13
Davis Selected Advisers
Arizona
$531M +$28.5M +226,659 +6%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$505M +$2.76M +21,953 +0.6%
Northern Trust
15
Northern Trust
Illinois
$498M +$5.97M +47,546 +1%
OAG
16
Orbis Allan Gray
Bermuda
$487M +$140M +1,115,267 +41%
AQR Capital Management
17
AQR Capital Management
Connecticut
$464M +$94.3M +751,166 +26%
Norges Bank
18
Norges Bank
Norway
$459M +$12.5M +99,426 +3%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$451M +$35M +279,133 +9%
Bank of America
20
Bank of America
North Carolina
$421M +$6.11M +48,639 +1%
O
21
OppenheimerFunds
New York
$418M -$96.7M -769,908 -19%
Goldman Sachs
22
Goldman Sachs
New York
$397M +$4.49M +35,796 +1%
Renaissance Technologies
23
Renaissance Technologies
New York
$397M +$33.7M +268,700 +9%
Ameriprise
24
Ameriprise
Minnesota
$331M -$12M -95,460 -4%
UBS AM
25
UBS AM
Illinois
$303M +$67.5M +537,604 +29%

AET Hedge Fund Activity: Q1 2017 in Review

880 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Aetna Inc (AET) for Q1 2017, worth a combined $39.4B — down 0.46% from $39.6B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new AET positions and 75 closed out — a net gain of 14 holders — while 304 added to existing stakes and 358 trimmed.

The largest buyer was BlackRock, adding an estimated $3.75B. The largest seller was T. Rowe Price Associates, cutting an estimated $890M.

  • 880 institutional investors held Aetna Inc (AET) as of Q1 2017, up from 877 in Q4 2016.
  • Funds reported $39.4B of Aetna Inc stock for Q1 2017, down 0.46% quarter-over-quarter.
  • 89 funds opened new Aetna Inc positions in Q1 2017 and 75 closed out, a net change of +14 holders.
  • The largest Aetna Inc buyer in Q1 2017 was BlackRock, an estimated $3.75B added.
  • The largest Aetna Inc seller in Q1 2017 was T. Rowe Price Associates, an estimated $890M sold.

Based on aggregated 13F filings for Q1 2017.